DURHAM, N.C., JUNE 2, 2018 — Premier Research is sharing the viewpoints and insights of its clinical trial experts through a podcast that launches today. The inaugural edition of the Premier Voices podcast focuses on rare oncology drug development, and its introduction coincides with the American Society of Clinical Oncology’s annual meeting June 1-5 in Chicago.
The first installment looks at:
- Using adaptive design to limit patient exposure to ineffective treatments and increase the overall likelihood of success
- Making the most of small and geographically dispersed patient populations
- Dealing with limitations such as a lack of defined biomarkers and baseline standard-of-care therapies
Check out Premier Voices. And if you’re attending ASCO June 1-5, visit Premier Research at Booth 17153.
About Premier Research
Premier Research is a leading clinical development service provider that helps biotech and specialty pharma innovators — small companies with big ambitions — transform life-changing ideas into new medicines. The company applies a relentless focus on quality in the execution of global, regional, and local clinical development programs with a special focus on addressing unmet needs in areas such as analgesia, dermatology, medical devices, neuroscience, oncology, pediatrics, and rare disease. Premier Research operates in 84 countries and employs 1,250 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. They are focused on smart study design for advanced medicines that transform breakthrough biotech thinking into reality.